11 West 42nd Street, 8th Floor New York, NY 10036
T: 1 646 630 7421
2 London Wall Place, London, EC2Y 5AU
T: 0207 113 1500
18 Robinson Road, Level 14-02, Singapore 048547
Av. Angélica, 2529 - Bela Vista, 6th Floor São Paulo - SP, 01227-200, Brazil
40-44 Bonham Strand, 7F Sheung Wan, Hong Kong
June 2019View Recording
AbstractDuring clinical trials, human biological samples are collected at clinical investigator sites over an extended period. Flawless administration of the chain of custody is critical to sample management because correct handling impacts both the course and results of clinical trials. Defective sample management can involve missing or contaminated samples, incomplete data, delays in reporting results, and substandard logistics. This leads to higher costs, lack of transparency, and other problems that can be avoided with the use of better technology like DLT. Q2 Solutions, a leading global clinical trial laboratory services organization that helps customers achieve better clinical trial outcomes, conducted a sample tracking proof-of-concept (POC) using distributed ledger technology (DLT, aka “blockchain”) in partnership with HSBlox, Inc. The goal of the POC was to explore real-time tracking of human biological samples in clinical trials. The POC simulated collection, transportation, test result generation, and storage of the sample. For the POC, HSBlox’s patent-pending Digital Sample Manager (DSM™) solution utilized R3’s Corda platform and was deployed in the Microsoft Azure cloud. View the recording today!
Stay up to date on the latest news and articles related to R3.